Dopamine transporter deficiency syndrome

From WikiMD's WELLNESSPEDIA

(Redirected from DAT Deficiency)

File:Dopamine Transporter.jpg
Dopamine Transporter

Dopamine transporter deficiency syndrome (DTDS), also known as infantile parkinsonism-dystonia, is a rare genetic disorder that affects the dopamine transporter (DAT), a protein responsible for the reuptake of dopamine from the synapse back into the presynaptic neuron. This condition leads to a significant reduction in dopamine levels in the brain, resulting in severe motor and neurological symptoms.

Genetics[edit]

DTDS is caused by mutations in the SLC6A3 gene, which encodes the dopamine transporter protein. These mutations can lead to a loss of function of the transporter, impairing dopamine reuptake and causing an accumulation of dopamine in the synaptic cleft. The disorder is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

Symptoms[edit]

The symptoms of DTDS typically appear in infancy or early childhood and may include:

Diagnosis[edit]

Diagnosis of DTDS is based on clinical evaluation, genetic testing, and the measurement of dopamine transporter function. Positron emission tomography (PET) scans can be used to assess the activity of the dopamine transporter in the brain. Genetic testing can confirm the presence of mutations in the SLC6A3 gene.

Treatment[edit]

There is currently no cure for DTDS, and treatment is primarily supportive and symptomatic. Management strategies may include:

Prognosis[edit]

The prognosis for individuals with DTDS varies depending on the severity of the symptoms and the effectiveness of the treatment. Early diagnosis and intervention can improve outcomes, but many individuals may experience significant motor and cognitive impairments throughout their lives.

See also[edit]

References[edit]


External links[edit]

-


Medical condition